CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 6757-6763

  Tenca, Claudya ^a   Merlo, Andrea ^a,c   Merck, Estelle ^b   Bates, Elizabeth E M ^b   Saverino, Daniele ^a   Simone, Rita ^a   Zarcone, Daniela ^a   Trinchieri, Giorgio ^b,d   Grossi, Carlo E ^a   Ciccone, Ermanno ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD85J ANTIGEN; FC RECEPTOR; GROWTH FACTOR; HUMAN OSTEOCLAST ASSOCIATED RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 8; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL ACTIVATION; CONTROLLED STUDY; CROSS LINKING; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 21044455153     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.6757     Document Type: Article

References (49)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9: 10-16.
3. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400.
4. Steinman, R. M., and J. Swanson. 1995. The endocytic activity of dendritic cells. J. Exp. Med. 182: 283-288.
5. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449.
6. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480-483.
7. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
8. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787.
9. Verhasselt, V., C. Buelens, F. Willems, D. De Groote, N. Haeffner-Cavaillon, and M. Goldman. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 158: 2919-2925.
10. Hartmann, G., G. J. Weiner, and A. M. Krieg. 1999. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96: 9305-9310.
11. Gambier, J. C. 1995. Antigen and Fc receptor signaling: the awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J. Immunol. 155: 3281-3285.
12. Thomas, M. L. 1995. Of ITAMs and ITIMs: turning on and off the B cell antigen receptor. J. Exp. Med. 181: 1953-1956.
13. Cambier, J. C. 1997. Inhibitory receptors abound? Proc. Natl. Acad. Sci. USA 94: 5993-5995.
14. Saverino, D., M. Fabbi, F. Ghiotto, A. Merlo, S. Bruno, D. Zarcone, C. Tenca, M. Tiso, G. Santoro, G. Anastasi, et al. 2000. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165: 3742-3755.
15. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16: 359-393.
16. Biassoni, R., C. Cantoni, D. Pende, S. Sivori, S. Parolini, M. Vitale, C. Bottino, and A. Moretta. 2001. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181: 203-214.
17. Colonna, M. 2003. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3: 445-453.
18. S cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3: 237-243.
19. Fournier, N., L. Chalus, I. Durand, E. Garcia, J. J. Pin, T. Churakova, S. Patel, C. Zlot, D. Gorman, S. Zurawski, et al. 2000. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily is expressed by human dendritic and myeloid cells. J. Immunol. 165: 1197-1209.
20. Fanger, N., D. Cosman, L. Peterson, S. C. Braddy, C. R. Mailszewski, and L. Borges. 1998. The MHC class I binding protein LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28: 3423-3434.
21. Kanazawa, N., K. Tashiro, K. Inaba, and Y. Miyachi. 2003. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor γ chain. J. Biol. Chem. 278: 32645-32652.
22. Colonna, M., J. Samaridis, M. Cella, L. Angman, R. L. Allen, C. A. O'Callaghan, R. Dunbar, G. S. Ogg, V. Cerundolo, and A. Rolink. 1998. Cutting edge: human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160: 3096-3100.
23. Borges, L., M. L. Hsu, N. Fanger, M. Kubin, and D. Cosman. 1997. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159: 5192-5196.
24. Long, E. O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17: 875-904.
25. Lopez-Botet, M., F. Navarro, and M. Llano. 1999. How do NK cells sense the expression of HLA-G class Ib molecules? Semin. Cancer Biol. 9: 19-26.
26. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282.
27. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809-1818.
28. Cosman, D., N. Fanger, and L. Borges. 1999. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers. Immunol. Rev. 168: 177-185.
29. Nikolova, M., P. Musette, M. Bagot, L. Boumsell, and A, Bensussan. 2002. Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling. Blood 100: 1019-1025.
30. Navarro, F., M. Llano, T. Bellon, M. Colonna, D. E. Geraghty, and M. Lopez-Botet. 1999. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29: 277-283.
31. Willcox, B. E., L. M. Thomas, and P. J. Bjorkman. 2003. Crystal structure of HLA-A2 boun to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4: 913-919.
32. Shiroishi, M., K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V. M. Braud, D. S. Allan, A. Makadzande, S. Rowland-Jones, B. Willcox, et al. 2003. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CDS for MHC class I binding and bind preferentially to HLA-G. Proc. Nat. Acad. Sci. USA 100: 8856-8861.
33. + T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol. 172: 5629-5637.
34. Leong, C. C., T. L. Chapman, P. J. Bjorkman, D. Formankova, E. S. Mocarski, J. H. Philips, and L. L. Lanier. 1998. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homology. J. Exp. Med. 187: 1681-1687.
35. Cella, M., C. Dohring, J. Samaridis, M. Dessing, M. Brockhaus, A. Lanzavecchia, and M. Colonna. 1997. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185: 1743-1751.
36. Merck E., C. Gaillard, D. M. Gorman, F. Montero-Julian, I. Durand, S. M. Zurawski, C. Menetrier-Caux, G. Carra, S. Lebeque, G. Trinchieri, and E. E. Bates. 2004. OSCAR is an FcRγ-associated receptor expressed by myeloid cells involved in antigen presentation and activation of human dendritic cells. Blood 104: 1386-1395.
37. Merck, E., B. de Saint-Vis, M. Scuiller, C. Gaillard, C. Caux, G. Trinchieri, and E. E. Bates. Fc receptor γ-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responses. Blood. In press.
38. Kim, N., M. Takami, J. Rho, R. Josien, and Y. Choi. 2002. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195: 201-209.
39. Cremer I., M. C. Dieu-Nosjean, S. Marechal, C. Dezutter-Dambuyant, S. Goddard, D. Adams, N. Winter, C. Menetrier-Caux, C. Sautes-Fridman, W. H. Fridman, and C. G. Mueller. 2002. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 100: 3646-3655.
40. Latour, S., H. Tanaka, C. Demeure, V. Mateo, M. Rubio, E. J. Brown, C. Malisewski, F. P. Lindberg, A. Oldenburg, A. Ulrich, et al. 2001. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-α: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J. Immunol. 167: 2547-2554.
41. Smith, R. E., V. Patel, S. D. Seatter, M. R. Deehan, M. H. Brown, G. P. Brooke, H. S. Goodridge, C. J. Howards, K. P. Rigley, W. Harnett, and M. M. Harnett. 2003. A novel MyD-1 (SIRP-1a) signaling pathway that inhibits LPS-induced TNFα production by monocytes. Blood 102: 2532-2540.
42. Newman, P. J. 1999. Switched at birth: a new family for PECAM-1. J. Clin. Invest. 103: 5-9.
43. Deaglio, S., M. Morra, R. Mallone, C. M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi. 1998. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 160: 395-402.
44. 2+ mobilization. Bichem. Biophys. Res. Commun, 320: 1228-1235.
45. Pålsson-Mcdermott, E. M., and L. A. O'Neil. 2004. Signal transduction by the lypopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153-162.
46. Ingalls, R. R., and D. T. Golenbock. 1995. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 181: 1473-1479.
47. Noubir, S., Z. Hmama, and N. E. Reiner. 2004. Dual receptor and distinct pathways mediate interleukin-1 receptor-associated kinase degradation in response to lipopolysaccharide: involvement of CD14/TLR4, CR3, and phosphatidylinositol 3-kinase. J. Biol. Chem. 279: 25189-25195.
48. Thellin, O., B. Coumans, W. Zorzi, A. Igout, and E. Keinen. 2000. Tolerance to the foetal-placental "graft": ten ways to support a child for nine months. Curr. Opin. Immunol. 12: 731-737.
49. Hviid, T. V. 2004. HLA-G genotype is associated with fetoplacental growth. Hum. Immunol. 65: 586-593.